MENU
+Compare
RICFY
Stock ticker: OTC
AS OF
Aug 5 closing price
Price
$14.82
Change
-$0.03 (-0.20%)
Capitalization
11.91B

RICFY Recordati Industria Chimica e Farmaceutica S.p.A. Forecast, Technical & Fundamental Analysis

Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals... Show more

RICFY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RICFY with price predictions
Aug 08, 2025

RICFY in downward trend: 10-day moving average moved below 50-day moving average on July 29, 2025

The 10-day moving average for RICFY crossed bearishly below the 50-day moving average on July 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RICFY as a result. In of 35 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

RICFY moved below its 50-day moving average on July 30, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RICFY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RICFY's RSI Oscillator exited the oversold zone, of 7 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RICFY advanced for three days, in of 24 cases, the price rose further within the following month. The odds of a continued upward trend are .

RICFY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 58 cases where RICFY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.577) is normal, around the industry mean (8.860). P/E Ratio (26.110) is within average values for comparable stocks, (22.896). Projected Growth (PEG Ratio) (1.092) is also within normal values, averaging (1.807). Dividend Yield (0.023) settles around the average of (0.030) among similar stocks. P/S Ratio (4.288) is also within normal values, averaging (3.246).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RICFY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RICFY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

View a ticker or compare two or three
RICFY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

RICFY paid dividends on June 05, 2025

Recordati Industria Chimica e Farmaceutica S.p.A. RICFY Stock Dividends
А dividend of $0.19 per share was paid with a record date of June 05, 2025, and an ex-dividend date of May 20, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
Via Matteo Civitali 1
Phone
+39 2487871
Employees
4369
Web
https://www.recordati.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
MBL.X0.002333-0.000022
-0.95%
MovieBloc cryptocurrency
KAVA.X0.393143-0.004956
-1.24%
Kava cryptocurrency
GDS36.37-0.90
-2.41%
GDS Holdings Limited
AUTO.X115.926580-2.996117
-2.52%
Auto cryptocurrency
ILV.X17.830580-0.826130
-4.43%
Illuvium cryptocurrency

Groups containing RICFY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RICFY
1D Price
Change %
RICFY100%
N/A
Pharmaceuticals: Major
industry (61 stocks)
18%
Poorly correlated
+0.00%
Pharmaceuticals
industry (394 stocks)
4%
Poorly correlated
+0.40%